** Shares of medical device maker STAAR Surgical STAA.O fall 3.5% to $25.7

** STAAR Surgical says it amendedits merger agreement with Swiss eyecare firm Alcon ALCC.S to add a 30-day "go‑shop" period through December 6, 2025, allowing co to actively solicit alternative takeover proposals

** Under the revised terms, STAAR will not owe Alcon a termination fee if it accepts a superior bid from a qualified third party during the go‑shop

** Alcon also waived its matching rights and agreed that STAAR does not have to share information about any incoming bids until the period ends

** STAAR postponed its special shareholder meeting to Dec. 19, 2025, to allow time for potential proposals and Alcon says it will engage with STAAR shareholders and proxy advisers to solicit support for the merger

** As of last close, STAA stock was up 4.9% YTD

(Reporting by Padmanabhan Ananthan)

((Padmanabhan.Ananthan@thomsonreuters.com))